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Abstract
Background: A complex network of signaling pathways and transcription factors regulates vertebrate mesoderm
development. Zebrafish mutants provide a powerful tool for examining the roles of individual genes in such a
network. spadetail (spt) is a mutant with a lesion in tbx16, a T-box transcription factor involved in mesoderm
development; the mutant phenotype includes disrupted primitive red blood cell formation as well as disrupted
somitogenesis. Despite much recent progress, the downstream targets of tbx16 remain incompletely understood.
The current study was carried out to test whether any of the five major signaling pathways are regulated by tbx16
during two specific stages of mesoderm development: primitive red blood cell formation in the intermediate
mesoderm and somite formation in the tail paraxial mesoderm. This test was performed using Gene Set
Enrichment Analysis, which identifies coordinated changes in expression among a priori sets of genes associated
with biological features or processes.
Results: Our Gene Set Enrichment Analysis results identify Wnt and retinoic acid signaling as likely downstream
targets of tbx16 in the developing zebrafish intermediate mesoderm, the site of primitive red blood cell formation.
In addition, such results identify retinoic acid signaling as a downstream target of tbx16 in the developing zebrafish
posterior somites. Finally, using candidate gene identification and in situ hybridization, we provide expression
domain information for 25 additional genes downstream of tbx16 that are outside of both pathways; 23 were
previously unknown downstream targets of tbx16, and seven had previously uncharacterized expression in
zebrafish.
Conclusions: Our results suggest that (1) tbx16 regulates Wnt signaling in the developing zebrafish intermediate
mesoderm, the site of primitive red blood cell formation, and (2) tbx16 regulates retinoic acid signaling at two
distinct embryonic locations and developmental stages, which may imply ongoing spatio-temporal regulation
throughout mesoderm development.
Background
Vertebrate mesoderm development is directed by a com-
plex network of signaling pathways and transcription
factors [1-6]. Most of the major signaling pathways –
TGF-b, FGF, Wnt, Delta-Notch, and retinoic acid – have
been identified, and many of their interactions have been
elucidated. For example, Nodal, BMP, Wnt, and FGF
pathways communicate in complex ways to specify both
cell fate and cell movement during gastrulation [4]; Wnt,
FGF, and Delta-Notch pathways interact with associated
transcription factors to direct segmentation [7]; and
BMP, Notch, and Wnt pathways interact with associated
transcription factors to regulate blood and vessel forma-
tion [8]. However, despite much progress, the diverse
ways in which these pathways interact to regulate cell
fate and morphogenesis remain an area of intense
research [1], and many more such interactions likely
remain uncharacterized.
Analysis of mutants displaying specific mesodermal
defects is a powerful tool with which to study the mole-
cular basis of mesoderm specification and morphogenesis
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t h em o r ef o c u s e dt h ea n a l y s i so fu n d e r l y i n gm o l e c u l a r
mechanisms that can be performed. spadetail (spt) is a
zebrafish mutant with a lesion in tbx16,aT - b o xg e n e
involved in mesoderm development [9,10]. T-box genes
are a family of transcription factors, distinguished by a
DNA binding domain (the “T-box”), that regulate numer-
ous developmental processes; the gene family likely arose
in the common ancestor of metazoans, and vertebrates
possess approximately 20 members [11]. spt mutants lack
trunk paraxial mesoderm because the appropriate meso-
dermal precursor cells mismigrate during gastrulation,
localizing in the tailbud instead of converging dorsally to
populate the trunk [12]. spt mutants have severely com-
promised primitive and definitive red blood cell forma-
tion [13,14] and irregular vasculature [15]; in some cases,
they lack pectoral fins, an anus, and a pronephric kidney
[14]. While trunk somites are absent, somewhat irregular
tail somites do form in spt mutants [14], concomitant
with intact segmentation clock gene expression machin-
ery [16]. Other mesoderm-derived tissues develop largely
normally. Thus, the zebrafish spt mutant is an excellent
system in which to examine the molecular mechanisms
underlying specific mesoderm-derived structures in an
otherwise largely unaffected embryo.
tbx16 is embedded in the network of signaling path-
ways and transcription factors involved in mesoderm
development, although not initial mesoderm induction
[17,18]. tbx16 expression is maintained by FGF signaling
from the mid-gastrula stage onward, and it also becomes
dependent on the T-box transcription factor no tail (ntl)
during somitogenesis. tbx16, in combination with ntl
and its paralog bra, in turn regulates expression of the
T-box transcription factor tbx6 in the trunk [9,19,20].
Additive, antagonistic, and combinatorial interactions
among ntl, tbx6,a n dtbx16 direct cell fate specification
in the developing mesoderm [21], and the specific
downstream targets/pathways mediating such specifica-
tion are incompletely understood and remain the focus
of intense study [19].
The role of tbx16 in specifying embryonic (primitive)
red blood cell fate has been examined in some detail
[13,22,23]. spt mutants lack red blood cell-specific gene
expression (e.g. ae1globin, be1globin, gata1 and jak2a),
indicating that red blood cell differentiation is not
initiated [22]. In addition, expression of early hemato-
poietic genes associated with blood progenitor formation
is absent, delayed, and/or downregulated in spt [22],
indicating that tbx16 acts prior to hematopoietic stem
cell specification. Significantly, transplant experiments
indicate that a novel signaling interaction between para-
xial and intermediate mesoderm necessary for specifying
primitive red blood cell fate is missing in spt mutants
[22]. Thus, tbx16 appears to play an additional, as-yet-
uncharacterized role in the network of transcription fac-
tors and signaling pathways necessary to specify meso-
derm fate. The current study was carried out to test
whether any of the five major signaling pathways are
regulated by tbx16 during two specific stages of meso-
derm development: primitive red blood cell formation in
the intermediate mesoderm and somite formation in the
tail.
As in other model organisms, microarray data have
been used in zebrafish to generate transcriptome profiles
during embryonic development [24] as well as to
explore the downstream effects of mutant alleles
[23,25,26]. Gene Set Enrichment Analysis (GSEA),
applied to microarray data, identifies coordinated
changes in expression among a priori sets of genes asso-
ciated with biological features or processes [27,28].
GSEA has been used to investigate zebrafish models of
human cancers [29-31] and more general questions in
developmental genomics [32]; however, this technique
has not been widely used to examine the effects of spe-
cific mutations during zebrafish development. Here, we
use GSEA to detect the spt-mediated disruption of
groups of genes comprising different signaling pathways.
We used both dissection and fluorescence activated cell
sorting (FACS) to isolate different mesodermal tissues
within the developing zebrafish embryo for genomic
analysis. We present (1) GSEA analyses of two develop-
ing mesoderm tissues that test for up- or downregula-
tion of the five major signaling pathways. Such analyses
identify Wnt and retinoic acid signaling as likely down-
stream targets of tbx16 in one or both developing tis-
sues, respectively; (2) microarray-based analyses of
individual downstream target genes of tbx16 in both tis-
sues; and (3) in situ hybridization-based exploration of
our microarray results, which yielded expression domain
data for 26 genes downstream of tbx16.T w e n t y - f i v e
such genes are outside of either disrupted signaling
pathway, 23 were previously unknown downstream tar-
gets of tbx16, and seven had previously uncharacterized
expression in zebrafish. More generally, our results sup-
port the utility of GSEA in zebrafish developmental
genomics [32].
Methods
Fish Strains
Fish were cared for and handled with standard techni-
ques [33]. Zebrafish harboring the recessive b104
mutant allele of the spt/tbx16 gene were crossed with a
transgenic line carrying the pax2a (previously pax2.1)
promoter fused to a GFP reporter gene [34]. Resulting
offspring were used for all microarray and in situ hybri-
dization analyses; spt
+/+ embryos (“wild-type,” hereafter)
were used as controls for comparison with spt
b104/b104
embryos (“spt” hereafter) in the microarray analyses, and
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+/+ and spt
b104/+ were used as “wild-type” con-
trols for in situ hybridization analyses. pax2a-GFP posi-
tive fish were used for 4/5-somite microarray analyses;
21-somite microarray analyses and all in situ hybridiza-
tion analyses used fish unsorted for pax2a-GFP. All
experiments and animal husbandry were carried out in
accordance with standards set by The University of Chi-
cago’s Animal Care and Use Committee (Protocol #
71112 to R. K. Ho).
Tissue Dissection, Fluorescence-Activated Cell Sorting,
and RNA extraction
RNA was extracted for microarray analysis at two
developmental stages: 4/5 somites (approximately 11.5
hours post-fertilization, or hpf) and 21 somites
(approximately 19.5 hpf). The 4/5-somite stage analysis
targeted the intermediate mesoderm, the site of tbx16-
dependent erythropoiesis. The 21-somite stage analysis
targeted the paraxial mesoderm, where tbx16 is
required for normal somitogenesis, but the tissue used
for RNA extraction also included other tissue types (e.
g. intermediate mesoderm, notochord, spinal cord).
Each RNA extraction procedure was repeated three
times from separate clutches of embryos. Embryos were
staged following Kimmel et al. (1995) [35]. At the 4/5-
somite stage, pax2a-GFP positive embryos were dis-
sected in Hanks’ solution; everything anterior to the
first somite, as well as the majority of the yolk, was
removed to eliminate fluorescence associated with
structures other than the intermediate mesoderm. The
remainder of the embryo was minced. Minced tissue
from eight embryos was combined and dissociated in
1.2 mL of 0.15% Trypsin (Sigma) and 2.4 U/mL Dispase
(Gibco) for one hour at room temperature with con-
stant stirring. Cells were passed through a 40 μm cell
strainer, pelleted, and resuspended in Hanks’. Cells
were sorted using a DakoCytomation MoFlo-HTS cell
sorter. Approximately 50 - 100 GFP-positive cells from
each sample were collected into 100 μLB u f f e rX B
(Arcturus). To the extent possible, the same numbers
of wild-type and spt cells were used as starting material
in each of the three replicates. Because fluorescent cell
n u m b e r sw e r es ol o w ,ap o r t i o no ft h es o r t e dc e l l
population was not re-run through the instrument to
quantify sort purity, as is routinely done; however, the
instrument was calibrated prior to each run using
beads to ensure that it was sorting at >99% purity.
Dead and dying cells were excluded using the FS vs. SS
morphology FACS profile. RNA was extracted using
the PicoPure Isolation Kit (Arcturus) according to the
manufacturer’s protocol. Two rounds of RNA amplifi-
cation were carried out using the RiboAmp HS RNA
Amplification Kit (Arcturus) according to the manufac-
turer’s instructions. At the 21-somite stage, embryos
were dissected in Daniaeu’s media; tissue including the
somites and pre-somitic mesoderm posterior to the
yolk-sac extension was collected from 150 wild-type
and spt embryos for each replicate. The posterior-most
tip of the tail in the wild-type embryos and the abnor-
mal ball of cells at the tip of the tail in the spt embryos
were removed. RNA was extracted using the PicoPure
Isolation Kit (Arcturus) according to the manufacturer’s
protocol. RNA integrity for both amplified and unam-
plified samples was assessed using an Agilent 2100
Bioanalyzer (Agilent Technologies, Palo Alto, CA).
Microarray Hybridization and Gene Set Enrichment
Analyses
Biotinylated cRNA was prepared from ~1-2 μgt o t a l
RNA (21-somite stage) or ~6 μg amplified RNA (4/5-
somite stage) and hybridized to Affymetrix GeneChip®
Zebrafish Genome Arrays by The University of Chicago
functional genomics core facility according to the manu-
facturer’s protocol. Image acquisition and initial array
quantification were performed using the Affymetrix
Microarray Suite Version 5.0. Gene sets for signaling
pathways and specific tissues were compiled from the
following sources: KEGG (Kyoto Encyclopedia of Genes
and Genomes) Pathway Database Section 3.2 (Environ-
mental Information Processing > Signal Transduction)
http://www.genome.jp/kegg/pathway.html; the Wnt
Homepage (R. Nusse, http://www.stanford.edu/~rnusse/
wntwindow.html; the gene ontology information in the
Affymetrix zebrafish array annotation; the ZFIN anato-
mical ontology browser http://zfin.org; OMIM http://
www.ncbi.nlm.nih.gov/omim/; and the literature. Only
g e n e sr e p r e s e n t e do nt h ea r r a yw e r ei n c l u d e di ng e n e
sets for GSEA. For signaling molecules that activate
multiple pathways (e.g. non-canonical vs. canonical
pathways activated by wnt ligands), the multiple path-
ways were combined into single gene sets for GSEA;
gene sets constructed for separate pathways yielded
gene sets too short for analysis. Gene sets ranged from
15 genes/splice variants (retinoic acid signaling list) to
194 genes/splice variants (somite list) and are included
as Additional file 1. Tissues from the two developmental
stages were analyzed separately. Affymetrix .CEL files
for the 21-somite arrays (wild-type and spt)w e r ec o m -
bined for enrichment analysis using the ExpressionFile-
Creator module of the GenePattern software package
(quantile normalization = yes, background correct =
yes), as were the 4/5-somite arrays (wild-type and spt).
GSEAs for the five signaling pathways and the positive
control tissue(s) were run using GSEA software http://
www.broad.mit.edu/gsea/ at the probe level (Collapse
dataset to gene symbols = false) with 1,000 gene set per-
mutations. Genes in the expression datasets were ranked
using the Signal2Noise metric (21-somite analysis) and
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ing GSEA recommendations for our sample sizes.
Probes for several genes were included in ≥ two gene
sets at both developmental stages: dvl2 and plcg1 for the
4/5-somite analysis, and dlc, dvl2, fgf8, fst, jag2, lfng,
map3k4, plcg1, sfrp5, smad1, wnt5b,a n dwnt11 for the
21-somite analysis. Because the inclusion of genes in
multiple gene sets can affect statistical significance
levels, analyses were repeated both including and
excluding these twelve genes. Significance was defined
at the False Discovery Rate (FDR) q-value = 0.10 level,
following suggestions by the GSEA creators that smaller
datasets analyzed with gene set permutation adopt a
more conservative FDR q-value cutoff than the default
0.25.
Because the zebrafish genome annotation is incom-
plete, GSEA of this array must contend with two poten-
tial problems: (1) multiple probe sets specifying the
same gene (EST cluster), and (2) unannotated probes.
We addressed these potential problems in several ways.
First, to address probe redundancy, we took the follow-
ing measures: (1) elimination from the gene set lists of
all redundant probes with known cross-hybridization
signal (denoted by _x_in Affymetrix notation), and (2)
elimination from the gene set lists of the non-expressed
probe when both sense and antisense probes exist for
the same EST subcluster. Redundant probes specifying
different EST subclusters and/or alternative transcripts
were all included in the analysis. Second, to address
incomplete probe annotation, we included in our analy-
sis two gene sets that describe tissues known to be
reduced or abnormal in the spt mutant. These gene sets
serve as positive controls, as they test whether the signal
contained in the zebrafish array is sufficient to be
detected by GSEA despite the noise of unannotated
probes, as well as any other sources of experimental
noise inherent in the microarray data. These positive
control gene sets contain genes associated with red
blood cells and somites. Red blood cell markers are
expected to be present in the wild type and downregu-
lated in spt in both 4/5- and 21-somite-stage tissues.
Somite markers (specifically somites 20-25) are expected
to be present in the wild type and perturbed in spt in
the 21-somite-stage tissue. Microarray results are depos-
ited in the Gene Expression Omnibus (Series #
GSE19955).
Candidate Gene Identification and In Situ Hybridization
Individual genes with different expression patterns in
wild-type vs. spt embryos were identified using the
dCHIP [36] and GeneSpring (Agilent Technologies,
Santa Clara, CA) software packages to achieve two aims:
(1) select genes whose array-based expression differ-
ences would be corroborated using different methods,
and (2) identify specific downstream targets of tbx16
involved in mesoderm development, either linked to or
outside of any identified signaling pathways. Groups of
arrays from the two developmental stages were analyzed
independently. Arrays were normalized using invariant
set normalization. Analyses were run on both filtered
and unfiltered data. For filtered analyses, probe sets with
expression levels below 100 in ≥ 50% of samples, or
called as “absent” in ≥ 80% of samples, were excluded
from further analyses. For unfiltered analyses, all probe
sets were included. One wild-type 4/5-somite stage
array was excluded from both candidate gene and GSEA
analyses because it did not cluster with the other wild-
type replicates (GeneSpring > Find Similar Samples ana-
lysis); further investigation of the expression of known
zebrafish red blood cell markers (e.g. gata1)i nt h i s
anomalous array showed expression levels up to two
orders of magnitude lower than in the other two wild-
type arrays. Genes that displayed a ≥ 1.25-fold (21-
somite microarray) or ≥ 1.5-fold (4/5-somite microarray)
change in expression between wild-type and spt embryos
were identified at each developmental stage (two-tailed
p < 0.05, median false discovery rate determined with
720 permutations). Distributions of p-values were exam-
ined to aid in interpreting false discovery rates. Forty-
eight genes identified as differentially expressed between
wild-type and spt tissues were screened by whole mount
in situ hybridization at either the 3-6-somite stage
(those identified by the 4/5-somite microarray) or the
21-somite stage (those identified by the 21-somite
microarray) (Table 1). The following antisense ribop-
robes for in situ hybridization were synthesized as
described: drl [37], jak2a [38], zeb2a (previously sip1a)
[39], hoxa11a [40], aldh1a2 (previously raldh2) [41],
and hsp90a.1 [42]. The following antisense riboprobe
was synthesized using a clone purchased from the Zeb-
rafish International Resource Center http://zebrafish.
org/zirc/home/guide.php: unc45b (clone ID cb393). To
make the rest of the riboprobes, clones were purchased
from Thermo Scientific Open Biosystems http://www.
openbiosystems.com. The Open Biosystem clone IDs for
such clones are: 4967423 (BI430182), 7289896
(zgc:171560), 7418866 (zgc:112524), 7055776 (zgc:92345),
7400556 (zgc:110288), 6793849 (cebpa), 6796795
(hmbsa), 3817707 (gtpbp1), 6790866 (calm1a), 7270071
(zgc:136864), 7432799 (zgc:153587), 3818293 (dnajc21),
8122978 (zgc:153390), 5913990 (ptgesl), 7417087
(zfyve21), 3818920 (ddx3), 6797250 (zgc:64161), 5915334
(rnaseh2b), 5410935 (nae1), 7000848 (zgc:77744),
3820017 (zgc:56033), 6800295 (zgc:66110), 6791918
(zgc:63962), 6805707 (atp6v1e1), 5600729 (pdap1),
6961180 (pinx1), 7001512 (exosc4), 5411920 (zgc:56136),
4787610 (znf593), 7923686 (LOC798291), 4789934
(zgc:73329), 7157357 (tcf25), 8148733 (clstn1), 7223265
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Affy
Probe ID
Gene
Name
a
Gene
Symbol
Corroborate
Microarray
b
Expression
Domain
c
Expression in
spt Embryos
d
Expression
Studies
Previously
Reported
Identified
by Array
Fold-
Change
in Array
Dr.16366.1.
S1_at
BI430182
e BI430182
f Yes IM downregulated No 4/5s -5.54
Dr.14123.1.
A1_at
zgc:171560 zgc:171560
f Yes ubiquitous downregulated No 4/5s -4.51
Dr.16573.3.
S1_x_at
zgc:112524 zgc:112524
f Yes ubiquitous downregulated No 4/5s -3.49
Dr.12443.1.
A1_at
zgc:92345 zgc:92345
f Yes ubiquitous downregulated No 4/5s -2.73
Dr.1085.2.
A1_at
zgc:110288 zgc:110288
f Yes ubiquitous downregulated No 4/5s -2.45
Dr.12055.1.
S1_at
CCAAT/enhancer binding protein
(C/EBP), alpha
cebpa
f Yes IM, ALPM downregulated Yes 4/5s -16.67
Dr.8064.1.
S1_at
draculin drl Yes IM downregulated Yes 4/5 s and
21s
-15.64
and
-3.65
Dr.3338.1.
S1_at
hydroxymethylb ilane synthase a hmbsa
f Yes IM, midline
structures
downregulated Yes 4/5s -4.56
Dr.515.1.
A1_at
GTP binding protein 1 gtpbp1
f Yes IM, midline
structures
downregulated Yes 4/5s -2.68
Dr.7908.1.
S2_at
calmodulin 1a calm1a
f, g Yes IM,
neuroectoderm
downregulated Yes 4/5s -2.11
Dr.4151.1.
S1_at
Janus kinase 2a jak2a Yes ubiquitous downregulated Yes 4/5s -4.64
Dr.21814.1.
S1_at
zgc:136864 zgc:136864 No -
Category A
ubiquitous same No 4/5s -5.73
Dr.1118.1.
A1_at
zgc:153587 zgc:153587 No -
Category A
ubiquitous same No 4/5s -4.44
Dr.883.1.
A1_at
DnaJ (Hsp40) homolog, subfamily
C, member 21
dnajc21 No -
Category A
ubiquitous same No 4/5s -2.52
Dr.14906.1.
A1_at
zgc:153390 zgc:153390 No -
Category A
ubiquitous same No 4/5s -2.21
Dr.16120.1.
S1_at
prostaglandin E synthase 2-like ptgesl No -
Category A
ubiquitous same Yes 4/5s -4.98
Dr.3023.1.
S1_at
zinc finger, FYVE domain
containing 21
zfyve21 No -
Category A
ubiquitous same Yes 4/5s -4.47
Dr.8412.1.
A1_at
DEAD (Asp-Glu-Ala-Asp) box
polypeptide 3
ddx3 No -
Category A
ubiquitous same Yes 4/5s -3.7
Dr.4269.1.
A1_at
zgc:64161 zgc:64161 No -
Category A
ubiquitous same Yes 4/5s -3.56
Dr.4468.1.
S1_at
ribonuclease H2, subunit B rnaseh2b No -
Category A
ubiquitous same Yes 4/5s -2.97
Dr.7212.1.
S1_at
nedd8 activating enzyme E1
subunit 1
nae1 No -
Category A
ubiquitous same Yes 4/5s -2.84
Dr.12643.1.
A1_at
zgc:77744 zgc:77744 No -
Category A
ubiquitous same Yes 4/5s -2.71
Dr.15269.1.
S1_at
zgc:56033 zgc:56033 No -
Category A
ubiquitous same Yes 4/5s -2.68
Dr.14026.1.
A1_at
zgc:66110 zgc:66110 No -
Category A
ubiquitous same Yes 4/5s -2.68
Dr.7237.1.
S1_at
zgc:63962 zgc:63962 No -
Category A
ubiquitous same Yes 4/5s -2.51
Dr.7966.1.
S1_at
ATPase, H+ transporting, lysosomal,
V1 subunit E isoform 1
atp6v1e1
f No -
Category B
polster,
neuroectoderm
downregulated No 4/5s -2.54
Dr.1791.1.
S1_at
pdgfa associated protein 1 pdap1
f No -
Category B
polster downregulated Yes 4/5s -4.25
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(Continued)
Dr.14426.1.
S1_at
pin2/trf1-interacting protein 1 pinx1
f No -
Category B
polster,
neuroectoderm,
PM
downregulated Yes 4/5s -3.04
Dr.9715.3.
S1_a_at
exosome component 4 exosc4
f No -
Category B
PM downregulated Yes 4/5s -3
Dr.7799.1.
A1_at
zgc:56136 zgc:56136
f No -
Category B
neuroectoderm downregulated Yes 4/5s -2.73
Dr.18052.1.
S1_at
zinc finger protein 593 znf593
f No -
Category B
neuroectoderm,
PM
downregulated Yes 4/5s -2.46
Dr.893.2.
S1_at
LOC798291 LOC798291 No -
Category C
PM same No 4/5s -2.32
Dr.9423.1.
S1_at
zgc:73329 zgc:73329 No -
Category C
PM same Yes 4/5s -3.25
Dr.1663.1.
A1_at
transcription factor 25 (basic helix-
loop-helix)
tcf25 No -
Category C
polster same Yes 4/5s -2.76
Dr.8822.1.
A1_at
zinc finger E-box binding
homeobox 2a
zeb2a No -
Category C
neuroectoderm same Yes 4/5s -3.6
Dr.25212.1.
A1_at
calsyntenin 1 clstn1 No -
Category C
Kupffer’s vesicle,
tail bud
same Yes 4/5s -3.28
Dr.12545.1.
S1_at
si:dkey-177p2.6 si:dkey-
177p2.6
No -
Category C
neuroectoderm,
PM
same Yes 4/5s -2.87
Dr.19223.1.
S2_at
aldolase c, fructose-bisphosphate aldoc No -
Category C
neuroectoderm same Yes 4/5s -5.23
Dr.25679.1.
S1_at
solute carrier family 1 (glial high
affinity glutamate transporter),
member 3a
slc1a3a No -
Category C
neuroectoderm same Yes 4/5s -3.05
Dr.1002.1.
S1_at
LOC568423 LOC568423
f
No -
Category D
ubiquitous upregulated No 4/5s -2.34
Dr.25683.5.
A1_at
sphingosine-1-phosphate receptor 1 s1pr1
f No -
Category D
neuroectoderm,
tailbud
upregulated Yes 4/5s -2.76
Dr.8183.1.
S1_at
homeo box A11a hoxa11a
f No -
Category D
tailbud upregulated Yes 4/5s -2.35
Dr.5206.1.
S1_at
aldehyde dehydrogenase 1 family,
member A2
aldh1a2 Yes PM, eyes downregulated Yes 21s -6.16
Dr.1817.1.
A1_at
regulator of calcineurin family
member 3
rcan3
f Yes PM downregulated Yes 21s -2.72
Dr.23348.1.
A1_at
bone morphogenetic protein 3 bmp3
f, g Yes PM,
neuroectoderm
downregulated Yes 21s -1.68
Dr.610.1.
S1_at
heat shock protein 90-alpha 1 hsp90a.1
f,
g
Yes PM downregulated Yes 21s -2.26
Dr.345.1.
S1_at
unc-45 homolog B (C. elegans) unc45b
f, g Yes PM downregulated Yes 21s -2.39
Dr.26455.1.
S1_at
fibroblast growth factor receptor-
like 1a
fgfrl1a
f, g Yes PM, eyes downregulated Yes 21s -1.73
a Gene names are consistent with those in ZFIN (The Zebrafish Model Organism Database, http://zfin.org/) whenever possible.
b “Yes” is defined as intermediate mesoderm expression (for genes from the 4/5s microarray) or paraxial mesoderm expression (for genes from the 21s
microarray) that is downregulated in spt. Category A is defined as ubiquitous expression that is not changed in spt. Category B is defined as expression that is
downregulated in spt but that is absent from the intermediate mesoderm. Category C is defined as expression that is unchanged in spt and absent from the
intermediate mesoderm. Category D is defined as expression upregulated in spt.
c Abbreviations are ALPM (anterior lateral plate mesoderm), IM (intermediate mesoderm) and PM (paraxial mesoderm).
d Downregulated is defined as at least part of the expression domain being reduced compared to the wild type based on visual detection. Upregulated is
defined as at least part of the expression domain being enhanced, and no part of the expression domain being reduced, compared to the wild type, based on
visual detection.
e EST ID is used here because this Affy probe is annotated by EST only and has not been assigned to an annotated gene. All of the other candidates explored by
in situ hybridization have been linked to annotated genes.
f These genes, to our knowledge, have not previously been revealed to act downstream of tbx16.
g These genes were identified as differentially expressed by the unfiltered analyses only; all other candidates explored by in situ hybridization were identified by
the filtered analyses.
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Page 6 of 16(si:dkey-177p2.6), 6792738 (aldoc), 7001080 (slc1a3a),
6893660 (LOC568423), 6894907 (s1pr1), 7036656
(rcan3), 7052011 (bmp3), and 6794698 (fgfrl1a). In the
event that such clones contained no RNA polymerase
sites flanking the inserts, inserts were sub-cloned into
pBluescript using appropriate restriction enzymes before
riboprobes were synthesized. In situ hybridization was
performed as previously described [43] using NBT/BCIP
as the enzyme substrates, except that 0.2× SSC was
replaced with 0.05× SSC. In the cases of certain probes
such as gtpbp1 and calm1a, expression level within the
intermediate mesoderm is lower than that outside of the
intermediate mesoderm. Hence, NBT/BCIP developing
time was extended to allow visualization of the specific
intermediate mesoderm expression, resulting in over-
staining of expression domains outside of the intermedi-
ate mesoderm. Following in situ hybridization, some of
the embryos were de-yolked and flat-mounted before
photographs were taken (Figure 1, A’-L’). Although
in situ hybridization is only a semi-quantitative mea-
surement of differential expression, one goal of our
study was to ascertain the usefulness of this method for
identification of developmentally significant expression
domain information; thus, this measurement was used
in preference to more quantitative measurements for
array corroboration (e.g. qPCR), which would not have
provided region-specific differential expression informa-
tion. Similar studies in zebrafish developmental geno-
mics have shown the combination of microarray analysis
and in situ hybridization to be an effective strategy for
identifying differentially expressed genes between wild-
type and mutant embryos [23,26].
Results
Gene Set Enrichment Analysis
GSEA [28] was performed to determine whether specific
signaling pathways specified ap r i o r iwere altered in spt
at different developmental stages. The following five
major signaling pathways were examined: (1) Wnt, (2)
Delta-Notch, (3) TGF-b, (4) retinoic acid, and (5) FGF.
4/5-Somite Intermediate Mesoderm Tissue Analysis
As described above, intermediate mesoderm cells were
isolated by FACS sorting of pax2a-GFP positive cells in
both otherwise wild-type and spt mutant embryos. The
wild-type tissues contained slightly higher relative num-
bers of GFP-positive cells (1.5% - 5%) than did the spt
tissues (0.38% - 3.2%); variation among runs likely
reflects variable fluorescence levels among individual
pax2a-GFP fish. The red blood cell gene set (Additional
file 1), which serves as our positive control, is signifi-
cantly downregulated in spt as expected based on the
mutant phenotype (FDR q = 0.000, NES = - 2.468). This
implies that (1) the zebrafish array annotation is suffi-
cient to provide information at this level of analysis and
( 2 )t h ea r r a yd a t ac o n t a i nas u f ficiently high signal-to-
noise ratio for GSEA. The Wnt signaling pathway gene
list is significantly upregulated in spt relative to wild-
type tissue (FDR q = 0.034, NES = 1.574) and the reti-
noic acid pathway is significantly downregulated in spt
(FDR q = 0.067, NES = -1.344). The other three signal-
ing pathways examined are not significantly up- or
downregulated in spt 4/5-somite intermediate mesoderm
tissue at the FDR q = 0.1 level (TGF-b FDR q = 0.415,
NES = 1.110; Delta-Notch FDR q = 0.455, NES = 1.171;
FGF FDR q = 0.349, NES = 1.081). Reanalysis excluding
the two genes present in multiple gene sets yields simi-
lar results (red blood cell FDR q = 0.0, NES = -2.470;
Wnt FDR q= 0.029, NES = 1.558; retinoic acid FDR q =
0.069, NES = -1.333; TGF-b FDR q = 0.415, NES =
1.110; Delta-Notch FDR q = 0.455, NES = 1.171; FGF
FDR q = 0.350, NES = 1.081). Fifteen of the 60 total
genes (16 of 70 total probes) comprising the Wnt gene
list contribute to the leading-edge subset, whose expres-
sion levels drive the signal of Wnt upregulation in spt;
14 of these genes (14 of 66 total probes) contribute to
the leading-edge subset when genes present in multiple
gene sets are excluded (Additional file 2). Two of the 15
total genes (four of 19 total probes) comprising the reti-
noic acid gene list contribute to the leading-edge subset;
this result is identical both including and excluding
genes present in multiple gene sets (Additional file 2).
21-Somite Tail Tissue Analysis
In spt embryos, trunk somitic mesoderm is largely
absent due to the mis-migration of mesodermal cells
during gastrulation [12]. However, in the spt tail region
(defined roughly as the area behind the hindyolk where
somites 17-32 would normally reside in wild-type
embryos), somitic mesoderm structures are present. Iso-
lation of the entire middle tail region, as outlined in the
methods section, allowed us to compare gene expression
profiles from a variety of tissues in wild-type versus spt
embryos. Both the red blood cell gene set and the
somite gene set (Additional file 1), which serve as posi-
tive controls, are significantly downregulated in spt as
expected based on the mutant phenotype (red blood cell
FDR q = 0.000, NES = -2.660; somite FDR q = 0.000,
NES = -2.731); thus, these array data also contain a suf-
ficiently high signal-to-noise ratio for GSEA analysis,
and annotation is sufficient. The retinoic acid signaling
pathway is significantly downregulated in spt relative to
wild-type tissue (FDR q = 0.049, NES = -1.410). No
other signaling pathway gene lists are significantly up-
or downregulated in spt for the 21-somite tail tissue
(Wnt FDR q = 0.615, NES = 1.091; TGF-b FDR q =
0.609, NES = 1.000; Delta-Notch FDR q = 0.673, NES =
0.889; FGF FDR q = 0.793, NES = 1.173). Reanalysis
excluding the 12 genes present in multiple gene sets
yields similar results (red blood cell FDR q = 0.000,
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Page 7 of 16Figure 1 Expression of validated candidate genes from the 4/5-somite microarray. Changes in the expression of BI430182 ( A ,B ,A ’,B ’),
cebpa (C, D, C’,D ’), drl (E, F, E’,F ’), hmbsa (G, H, G’,H ’), gtpbp1 (I, J, I’,J ’) and calm1a (K, L, K’,L ’) were visualized using in situ hybridization in wild-
type (A, A’,C ,C ’,E ,E ’,G ,G ’,I ,I ’, K and K’) and spt embryos (B, B’,D ,D ’,F ,F ’,H ,H ’,J ,J ’, L and L’). All embryos are oriented with posterior to the
right. Whole-mount embryos (A-L) are shown in lateral view while de-yolked and flat-mounted embryos (A’-L’) are shown in dorsal view. Flat-
mounted embryos (A’-L’) show only the posterior half of the embryos for high-magnification view. All embryos were fixed at the 3 to 6-somite
stage. Arrowheads point to specific intermediate mesoderm expression domains.
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Page 8 of 16NES = -2.627; somite FDR q = 0.000, NES = 2.735; reti-
noic acid FDR q = 0.057, NES = -1.382; Wnt FDR q =
1.0, NES = 1.137; TGF-b FDR q = 0.641, NES = 0.902;
Delta-Notch FDR q = 0.712, NES = 0.955; FGF FDR q =
0.832, NES = 1.020).
In summary, GSEA results from both 4/5- and 21-
somite analyses share significant downregulation of the
retinoic acid pathway as well as red blood cell genes,
which serve as a positive control for the analyses; how-
ever, the two results differ in that the Wnt pathway is
significantly upregulated in the 4/5-somite, but not in
the 21-somite, analysis.
Candidate Gene Identification and In Situ Hybridization
In addition to analyses of signaling pathway sensitivity
to the spt mutation, candidate gene identification ana-
lyses were performed to search for individual down-
stream target genes of tbx16 involved in mesoderm
development, either linked to or outside of Wnt and
retinoic acid signaling, as well as to explore the reliabil-
ity of the microarray results. Candidate gene analysis
comparing wild-type and spt tissue at the 4/5-somite
stage yielded 182 genes (median false discovery rate =
60.4%) and 112 genes (median false discovery rate =
59.8%) for unfiltered and filtered analyses, respectively.
C a n d i d a t eg e n ea n a l y s i sc o m p a r i n gw i l d - t y p ea n dspt
tissue at the 21-somite stage yielded 239 genes (median
false discovery rate = 3.8%) and 58 genes (median false
discovery rate = 1.7%) for unfiltered and filtered ana-
lyses, respectively. A high FDR, such as that characteriz-
ing the 4/5-somite analysis, can signify either clean data
with a distribution of p-values in which no more genes
have p ≤ 0.05 than would be expected by chance (as is
t h ec a s ef o rt h e4 / 5 - s o m i t ea n a l y s i s ) ,o rn o i s yd a t a ,
which particularly impacts candidate selection based on
p-values [44]. All gene lists are included in Additional
file 3.
A subset of these candidates was screened by in situ
hybridization to (1) perform semi-quantitative corro-
boration of the array results, and (2) further evaluate
potential candidates for functional studies (presented
elsewhere) based on expression domains. A total of 48
genes were screened, 41 of which were identified by the
4/5-somite array analyses, six of which were identified
by the 21-somite array analyses, and one of which was
identified by both; our emphasis on the 4/5-somite array
analyses reflects both the significant GSEA results for
Wnt and retinoic acid signaling as well as the extremely
high false-discovery rate of the candidate gene analysis.
Genes downregulated in spt were chosen because of the
demonstrated roles of T-box genes as transcriptional
activators [45,46]; fold-changes for differential expres-
sion between spt and wild-type ranged from -1.68 to
-16.67 among the 48 genes. In situ hybridization results
confirm a high false-positive rate for the 4/5-somite
microarray and a low false-positive rate for the 21-
somite microarray; “false-positive” is defined as signifi-
cantly lower expression in spt compared to wild-type
embryos in the intermediate mesoderm (for the 4/5-
somite microarray) or the tail paraxial mesoderm (for
the 21-somite microarray) detected by microarray analy-
sis but not by in situ hybridization. We note that we did
not include any compound in our FACS sorting to
exclude 100% of dead and dying cells (e.g. propidium
iodide), which may have contributed to the high false-
positive rate of the 4/5-somite microarray; however, we
did use the FS vs. SS morphology profile, which allowed
the exclusion of many such unwanted cells.
In Situ Hybridization of 4/5-Somite Array Candidates
We performed in situ hybridization with embryos at the
3-6-somite stage for 42 genes chosen from the 4/5-
somite microarray results (Table 1). Twenty-six percent
(11/42) of the genes identified as downregulated in spt
intermediate mesoderm by the 4/5-somite array analysis
were also shown to have reduced expression in spt
intermediate mesoderm by in situ hybridization (Table
1, lines 1-11; Figure 1); 33% (14/42) were shown to have
equivalent expression between wild-type and spt inter-
mediate mesoderm (Table 1, Category A); 14% (6/42)
were shown to have lower expression in spt than in the
wild type, but expression was only detected outside of
the intermediate mesoderm (Table 1, Category B); 19%
(8/42) were shown to have equivalent expression
between spt and the wild type, but expression was only
detected outside of the intermediate mesoderm (Table
1, Category C); and 7% (3/42) were shown to have
higher expression in spt than in the wild type, contrary
to the array results (Table 1, Category D). We note that
RNA amplification can double the relative noise in
microarray analyses by distorting expression ratios
between control and experimental tissues [47]; thus, we
cannot be sure that all downregulated genes identified
by the array would have sufficiently different expression
levels between wild-type and spt tissues to be detectable
by in situ hybridization. Because of this, Category A and
C genes do not clearly refute the array results, although
they do not corroborate them, either. Category B and C
genes, which do not show discernible expression in the
intermediate mesoderm by in situ hybridization, may
reflect imperfect cell sorting; however, Category B genes
have reduced expression in spt, consistent with the array
results. Category D genes are inconsistent with the array
results. Taken together, these in situ results confirm a
high false-positive rate for the array analysis. However,
the false positive rate begins to decline as fold-change
increases above 4-fold. This suggests that accuracy
of the 4/5-somite intermediate mesoderm microarray
analysis improves for larger fold-changes. Noise
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Page 9 of 16preferentially impacting smaller fold-changes, particu-
larly if it is directionally unbiased, is less likely to mis-
lead GSEA, which focuses on detecting gene sets that
are over-represented at the extremes of the overall fold-
change distribution in a dataset [28]. In total, three lines
of evidence suggest the presence of detectable signal in
the 4/5-somite dataset, despite such high levels of noise:
(1) downregulation of our positive control gene set (red
blood cell-specific genes) was highly significant; (2)
false-positives declined as fold-changes increased above
4-fold, indicating that our 4/5-somite array analyses can
more accurately detect larger fold-changes; and (3) inde-
pendent lines of evidence from other experimental sys-
tems are also beginning to link Wnt signaling with
blood formation [48-50]. These results confirm that
GSEA can identify broader patterns of coordinated gene
expression, despite low signal and/or significant noise in
microarray data [27,28].
Despite the noise associated with candidate gene
selection, our in situ hybridization results confirm speci-
fic intermediate mesoderm expression of cebpa (Figure
1c-d’)[ 5 1 ]a n ddrl (Figure 1e-f’)[ 3 7 ] .W ea l s or e p o r t
specific intermediate mesoderm expression of BI430182
(Figure 1a-b’), hmbsa (Figure 1g-h’), gtpbp1 (Figure 1i-
j’), and calm1a (Figure 1k-l’), whose intermediate meso-
derm expression at the 3-6-somite stage was not pre-
viously revealed. In all six cases, expression is reduced
in spt, suggesting that they are downstream targets of
tbx16. Five of these six genes were not previously
understood to function downstream of tbx16,w h i l ea
sixth (drl) has previously been implicated to act down-
stream of tbx16 in red blood cell specification in the
zebrafish intermediate mesoderm [22]. In addition, we
report expression domain data for 11 genes whose
expression has not previously been reported, six of
which are also novel downstream targets of tbx16:( 1 )
zgc:171560,( 2 )zgc:112524,( 3 )zgc:92345,a n d( 4 )
zgc:110288 have ubiquitous expression domains and are
novel downstream targets of tbx16 with reduced expres-
sion in spt.( 5 )atp6v1e1 is expressed in the polster and
neuroectoderm and is a novel downstream target of
tbx16 with reduced expression in spt.( 6 )LOC568423
has ubiquitous expression and is a novel downstream
target of tbx16 with increased expression in spt.( 7 )
zgc:136864,( 8 )zgc:153587,( 9 )dnajc21,a n d( 1 0 )
zgc:153390 have ubiquitous expression domains with no
apparent expression perturbation in spt detectable by in
situ hybridization. (11) LOC798291 is expressed in para-
xial mesoderm with no apparent expression perturba-
tion in spt detectable by in situ hybridization. Finally,
we report seven additional genes whose wild-type
expression was previously known, but that we reveal to
be downstream targets of tbx16:( 1 )pdap1 is expressed
in the polster and is a novel downstream target of
tbx16 with reduced expression in spt.( 2 )pinx1 is
expressed in the polster, neuroectoderm, and paraxial
mesoderm and is a novel downstream target of tbx16
with reduced expression in spt.( 3 )exosc4 is expressed
in the paraxial mesoderm and is a novel downstream
target of tbx16 with reduced expression in spt.( 4 )
zgc:56136 is expressed in the neuroectoderm and is a
novel downstream target of tbx16 with reduced expres-
sion in spt. (5) znf593 is expressed in the neuroecto-
derm and paraxial mesoderm and is a novel
downstream target of tbx16 with reduced expression in
spt.( 6 )s1pr1 is expressed in the neuroectoderm and
tail bud and is a novel downstream target of tbx16 with
increased expression in spt.( 7 )hoxa11a is expressed in
the tail bud and is a novel downstream target of tbx16
with increased expression in spt. We note that our cur-
rent analysis cannot distinguish between differential
expression in the spt mutant caused by different expres-
sion levels in the same number of cells or different
numbers of cells expressing such genes at the same
level. In summary, our in situ hybridization results
reveal that candidate selection based solely on p-values
for RNA amplified from a few (50-100) intermediate
mesoderm cells at the 4/5-somite stage yields high false
positive rates, although interesting candidate genes were
still identified for follow-up using expression data.
Overall trends toward increased accuracy with higher
fold-changes suggest that more global analyses of coor-
dinated gene expression (e.g. GSEA) are still likely to be
able to extract meaningful biological signal from such
data; the detection of our positive control (red blood
cell) gene set by GSEA further corroborates this.
In Situ Hybridization of 21-Somite Candidates
We performed in situ hybridization with embryos at the
21-somite stage for six genes chosen from the 21-somite
microarray results: aldh1a2, rcan3, bmp3, hsp90a.1,
unc45b,a n dfgfrl1a (Table 1, Figure 2). Such results
identify a specific expression domain within the paraxial
mesoderm for bmp3, whose whole-embryo expression
has not previously been reported (Figure 2e-f). In addi-
tion, we confirm paraxial mesoderm expression in
aldh1a2 (Figure 2a-b) [41], rcan3 (Figure 2c-d) [52],
hsp90a.1 (Figure 2g-h) [42,53], unc45b (Figure 2i-j) [54],
and fgfrl1a (Figure 2k-l) [52]. For all six candidate
genes, in situ hybridization results corroborate the
microarray results in that the tail mesoderm expression
in spt is lower than its counterpart in the wild type. To
our knowledge, this study is the first to report that five
of these genes are downstream of tbx16;t h es i x t h
(aldh1a2) was recently shown to be regulated by tbx16
and ntl based on genomic analyses of T-box binding site
sequences [19]. In summary, we have identified six
genes acting downstream of tbx16 in the posterior
mesoderm at the 21-somite stage, only one of which
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signaling pathway (retinoic acid signaling).
As a final exploration of our microarray data, we com-
pared our results with those of another microarray ana-
lysis of downstream targets of tbx16 that used RNA
extracted from whole embryos at 75% epiboly and the
Compugen/Sigma-Genosys oligo library [19]. We exam-
ined ten genes/probes that were present on both the
Compugen and Affymetrix arrays and were shown to be
downregulated in spt by the Garnett et al (2009) [19]
study: her1, pcdh10b, egln3, wu:fb53f04, efnb2b, tbx6,
mespa, pcdh8, myf5,a n dmsgn1. Although our studies
examined different developmental stages and tissues, we
expect some consistency between these two datasets. In
our 21-somite results, eight of these ten genes are
downregulated in spt, consistent with Garnett et al. [19]:
her1, tbx6, mespa, myf5,a n dpcdh8 (all at p ≤ 0.05),
msgn1 (p = 0.07), pcdh10b (p = 0.12) and efnb2b (p =
0.7). The remaining two genes – egln3 and wu:fb53f04 –
w e r eu p r e g u l a t e d( p=0 . 0 9 )a n dn o td i f f e r e n t i a l l y
expressed (p = 0.13), respectively. However, we note
that efnb2b, egln3,a n dwu:fb53f04 were not present on
our filtered gene list, indicating that they are expressed
at extremely low levels at the 21-somite stage in the
specific tissues we examined. Thus, the differences
between our results and those of Garnett et al. may
reflect differences in wild-type expression levels between
the different developmental stages examined (75% epi-
boly and the 21-somite stage). Published expression data
are consistent with this; egln3 i sn o te x p r e s s e da tt h e
21-somite stage [52]. To our knowledge, no relevant
expression data exist for wu:fb53f04 or efnb2b.I no u r4 /
5-somite results, six of the ten genes were not present
on the filtered gene list, again suggesting that such
genes are not expressed in the intermediate mesoderm
at this developmental stage; to our knowledge, no defini-
tive evidence of intermediate mesoderm expression
exists for these six genes. Of the remaining four genes,
two are downregulated in spt, consistent with Garnett et
al. (2009): tbx6 (p = 0.4) and msgn1 (p = 0.3). The
remaining two are upregulated: pcdh10b (p = 0.59) and
wu:fb53f04 (p = 0.11). This discrepancy may reflect (1)
noise in our 4/5-somite microarray data, or (2) biologi-
cal differences in the effects of spt on these targets at
different developmental stages and/or in different tis-
sues. In summary, our study and that of Garnett et al.
partially corroborate one another, although more
detailed analysis of wild-type expression of the Garnett
et al. candidates in the tissues we examined would be
required to fully integrate our results. More generally,
studies looking at downstream targets of tbx16
Figure 2 Expression of validated candidate genes from the 21-
somite microarray. Changes in the expression of aldh1a2 (A, B),
rcan3 (C, D), bmp3 (E, F), hsp90a.1 (G, H), unc45b (I, J) and fgfrl1a (K,
L) were visualized using whole mount in situ hybridization in wild-
type embryos (A, C, E, G, I and K) and spt embryos (B, D, F, H, J and
L). All embryos are shown in lateral view with anterior to the left. All
embryos were fixed at the 21-somite stage.
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will be required to gain a comprehensive understanding
of tbx16’s role in mesoderm development.
Discussion
tbx16/spt and Wnt Signaling
To our knowledge, our results are the first to specifically
demonstrate that Wnt signaling lies downstream of
tbx16. More generally, such results are broadly consis-
tent with several recent studies examining Wnt signal-
ing, T-box genes, and blood development. Analyses
identifying direct targets of both tbx16 and its close T-
box family members ntl and bra [19,20] have confirmed
that tbx16 and Wnt co-regulate gene expression that
drives mesoderm development [55]. Using microarray
analyses of RNA from tbx16 and ntl morpholino-
injected embryos at 75% epiboly, in combination with
binding site prediction and genome searches, Garnett et
al. (2009) [19] identified another T-box gene, tbx6,a sa
direct target of both tbx16 and ntl.N o t a b l y ,t h etbx16
and ntl binding sites were interspersed with Tcf/Lef-
binding sites that are crucial for tbx6 expression to be
responsive to Wnt signaling [56]. Thus, tbx6 is directly
regulated by both tbx16 and Wnt signaling, as well as
ntl; other putative tbx16/Wnt co-regulated targets were
also identified, although their detailed investigation has
not yet been carried out [19]. Martin and Kimelman
(2008) revealed positive regulatory feedback between
ntl/bra and canonical Wnt signaling in zebrafish meso-
derm progenitors, demonstrating another interaction
between canonical Wnt signaling and T-box genes. We
have identified a novel way in which tbx16 and Wnt sig-
naling interact, contributing to the emerging picture of
T-box/Wnt interactions that regulate gene expression in
the developing mesoderm.
Wnt signaling plays several known roles during the
development of red blood cells, acting on different cell
populations at stages spanning mesoderm induction to
primitive erythroid specification. Such roles have been
documented in zebrafish and other organismal and
embryonic stem cell (ES) experimental systems
[49,50,57]. Lengerke et al. (2008) showed that, in murine
ES cells and zebrafish, Wnt signaling, in conjunction
with BMP, activates the Cdx-Hox pathway and that this
BMP – Wnt – Cdx – Hox sequence is required for
hemangioblast specification [48]. Similarly, Nostro et al.
(2008) demonstrated that canonical Wnt signaling, BMP
signaling, and Activin/Nodal signaling work in concert
to specify Flk1+ mesoderm (which includes hemangio-
blast cells) in murine ES [49]. Most relevant to our
results, they also found that Wnt signaling, in the con-
text of VEGF stimulation, plays an indispensable role in
the specification of primitive erythroid progenitors from
Flk1+ cells; in contrast, neither BMP nor Activin/Nodal
signaling was required at this stage [50]. Cheng et al.
(2008) also demonstrated that canonical Wnt signaling
is required for the establishment of the primitive ery-
throid lineage from the hemangioblast and that Notch
signaling inhibits primitive erythroid development by
inhibiting the Wnt pathway [47]. Taken together, these
studies underscore the important point that Wnt signal-
ing acts multiple times on different cell populations dur-
ing development of primitive red blood cells.
Identifying and integrating all roles for Wnt signaling
during hematopoiesis into a larger regulatory network
that includes additional pathways (e.g. trf3 – mespa –
cdx4 [58]) and individual hematopoietic genes (e.g.
gfi1.1, survivin [59,60]) remains an important goal
[61,62]. Embryonic stem cell studies allow the identifica-
tion of Wnt pathway effects at discrete time points in
development; however, our microarray analysis targeting
a specific tissue (the intermediate mesoderm) at a speci-
fic developmental stage (4/5-somites) allows even finer-
scale analysis because we can map Wnt pathway activity
to specific tissue types in vivo. This allows us to inte-
grate additional types of developmental data with micro-
array and ES results to generate more refined
hypotheses that address both temporal and spatial
aspects of tbx16 /Wnt function in the developing
embryo. For example, cell transplantation studies in zeb-
rafish embryos have demonstrated that (1) the embryo-
nic microenvironment for red blood cell formation in
the intermediate mesoderm requires an interaction
between intermediate mesoderm and the adjacent para-
xial mesoderm, and (2) tbx16 is required cell-autono-
mously in the intermediate mesoderm in order to
properly respond to the paraxial mesoderm signal [22].
Existing expression data in zebrafish suggest the hypoth-
esis that the BMP – Wnt – Cdx – Hox pathway identi-
fied by Lengerke et al. (2008) [48] may correspond to
some aspect of paraxial mesoderm signal production (or
competence enabling signal production) in zebrafish.
Specifically, cdx4 and cdx1a, the caudal type homeobox
transcription factors involved in primitive hematopoiesis
in zebrafish, are both primarily expressed in the paraxial
mesoderm [63,64], as are the posterior hox genes under
the transcriptional regulation of the cdx genes [64]. In
contrast, the tbx16-dependent Wnt signaling identified
by our GSEA analysis is likely part of the response to
this as-yet-unknown signal in the intermediate meso-
derm and may correspond to the Wnt-dependent transi-
tion from Flk1+ cells to erythroid progenitors identified
in murine ES cells [48,50]. Additionally, Garnett et al.
(2009) [19] identified cdx4 as a putative target of tbx16
/Wnt co-regulation, which suggests the hypothesis that
tbx16 m a yb ep a r to ft h eB M P– Wnt – Cdx – Hox
p a t h w a y[ 4 9 ]t h a tm a yf u n c t i o ni nz e b r a f i s hp a r a x i a l
mesoderm. Because spt embryos lack trunk paraxial
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ascertain whether tbx16 functions in the trunk paraxial
mesoderm beyond controlling the correct migration of
precursor cells during gastrulation to include any more
direct role(s) in signal production [22]. Other types of
experimental manipulations will be required to rigor-
ously test the hypothesized roles for tbx16 and Wnt sig-
naling in both paraxial mesoderm signal production and
intermediate mesoderm signal reception generated by
incorporating our microarray results with other develop-
mental genetic, genomic, and ES studies.
In summary, previous research has suggested (1) a role
for Wnt signaling in specification of both the hemangio-
blast and the primitive erythroid progenitor lineage, as
well as (2) combined regulatory interactions between
tbx16 and Wnt during diverse stages of mesoderm
development. Our results suggesting that tbx16 regulates
Wnt signaling during the specification of red blood cell
progenitors in the zebrafish intermediate mesoderm are
thus consistent with previous studies, but add a new
level of detail. Such detail was made possible through
gene expression analyses targeted to a specific tissue
and developmental stage, informed by cell transplanta-
tion studies in live embryos. Thus, embryological manip-
ulation and genomics can be integrated to generate
novel insights in developmental genomics.
Our GSEA looked for effects of spt on a set of genes
that included both canonical and non-canonical Wnt
pathway members; thus, we tested the effects of tbx16
on both canonical and non-canonical Wnt signaling
simultaneously. The results demonstrate that both cano-
nical and non-canonical pathways are disrupted. More
specifically, the leading edge subset of genes, whose
expression levels drive the signal of Wnt upregulation in
spt, contains Wnt ligands and Frizzled receptors impli-
cated in both signaling pathways (e.g. canonical wnt8
and fzd10, non-canonical wnt11 and fzd7). These results,
too, are consistent with recent ES studies implicating
both canonical and non-canonical Wnt signaling during
hematopoiesis. Vijayaragavan et al. (2009) revealed a
role for non-canonical Wnt signaling in human ES dur-
ing Stage I of hematopoiesis, which encompasses
hemangioblast formation, as well as canonical Wnt sig-
naling during Stage II, which includes formation of
committed hematopoietic progenitors; other studies
have also demonstrated early roles for non-canonical
Wnt signaling during blood formation [65,66]. More
generally, work continues to demonstrate that many
pathway members act in both canonical and non-cano-
nical signaling [67-69], suggesting that the traditionally
separate canonical and non-canonical Wnt signaling
pathways are better represented as an integrated Wnt
signaling network [62,70]. Thus, our finding that both
canonical and non-canonical components are impacted
in spt intermediate mesoderm is not surprising and may
lend support to an integrated Wnt signaling network
acting in zebrafish hematopoiesis.
Although our GSEA results revealed an upregulation
of Wnt pathway/network components, predicting the
effects of such upregulation on Wnt target genes is not
straightforward. Within any signaling network, indivi-
dual components have very different effects on down-
stream target gene expression; both activators and
inhibitors exist, and components are integrated through
both positive and negative feedback loops [71-73] as
well as more complicated, dynamic interactions [62].
Thus, our results should be interpreted as a demonstra-
tion that Wnt signaling is disrupted; more targeted ana-
lyses of expression and function of network components
and downstream targets are required to elucidate the
specific effects of Wnt signaling disruption on hemato-
poietic gene expression.
Wnt signaling is not significantly disrupted in the 21-
somite tail tissue analysis. This finding is consistent with
previous studies demonstrating that canonical Wnt sig-
naling (specifically wnt3a and wnt8)i sr e q u i r e df o rt a i l
development in zebrafish [74]; given the relatively nor-
mal tail somites and presomitic mesoderm present in
the spt mutant, relatively unperturbed Wnt signaling is
not surprising. Furthermore, knocking out wnt8 expres-
sion in spt embryos results in the loss of all tail somites;
this suggests that Wnt signaling necessary for posterior
somite formation remains intact in spt mutants,
although Wnt signaling, tbx16, and ntl interact to gener-
ate both trunk and tail mesoderm [55]. Finally, segmen-
tation clock gene expression is intact in spt [16]; given
the role of Wnt signaling in regulating the segmentation
clock [75], intact Wnt signaling in posterior spt somites
is not unexpected.
tbx16/spt and Retinoic Acid Signaling
Our GSEA results are also broadly consistent with sev-
eral studies linking tbx16 with retinoic acid signaling
and intermediate mesoderm differentiation. Garnett
e ta l .( 2 0 0 9 ) ,a sd i dw e ,i d e n t i f i e daldh1a2,a ne n z y m e
that catalyzes the synthesis of retinoic acid, as a likely
direct target of tbx16 based on the large number of T-
box binding sites upstream, and within the intronic
sequences, of the gene [19]. Reduced expression of
aldh1a2 in somitic and intermediate mesoderm has also
been reported in both spt and spt/ntl mutant embryos
[76]. Notably, recent studies have identified a prominent
role for retinoic acid signaling, controlled by expression
of aldh1a2 (synthesis) and cyp26a1 (degradation), in
patterning the zebrafish pronephros, also derived from
the intermediate mesoderm [77]. Such retinoic acid sig-
naling is localized along the anterior/posterior axis by
cdx genes [77]. The downstream targets of retinoic acid
Mueller et al. BMC Genomics 2010, 11:492
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Page 13 of 16in the intermediate mesoderm, and how they contribute
to specification of pronephric or hematopoietic fate, are
just beginning to be understood [78,79]; BMP signaling
h a sa l s ob e e ns h o w nt oc o n t r i b u t et oh e m a t o - v a s c u l a r
vs. pronephric fate commitment [80]. Our result that
both retinoic acid and Wnt signaling are disrupted in
spt intermediate mesoderm suggests the additional
hypotheses that (1) retinoic acid regulates Wnt signal-
ing, or that (2) Wnt regulates retinoic acid signaling; the
latter has been shown previously in zebrafish during
gastrulation [81] and patterning of the neuroectoderm
[82]. Our result that retinoic acid signaling continues to
be disrupted at the 21-somite stage in the developing
tail somites is consistent with previous studies showing
that aldh1a2 expression contributes to both somite size
[83] and symmetry [84], as the anterior-most somites
formed in spt are somewhat irregular [14]. More gener-
ally, our results suggest that the effects of tbx16 on reti-
noic acid signaling may persist both spatially and
temporally throughout mesoderm differentiation in the
developing embryo.
The retinoic acid leading edge subsets of genes, whose
expression levels drive the signal of retinoic acid signal-
ing downregulation in both the intermediate mesoderm
(4/5-somite stage) and tail (21-somite stage), contain
both retinoic acid synthesis (e.g. aldh1a2, rdh1l)a n d
degradation (e.g. cyp26a1) enzymes. Again, the specific
effects of such perturbations on downstream targets of
retinoic acid signaling are difficult to predict. Our
results should be interpreted to reveal a general disrup-
tion of retinoic acid signaling in spt, the details of which
will require further analyses of pathway and target gene
expression and function.
Conclusions
Our study examined the effects of the spt mutation on
zebrafish embryonic gene expression profiles at two
developmental stages and discrete embryonic locations
(4/5-somite intermediate mesoderm and 21-somite ante-
rior tail tissue) using microarrays. We performed both
GSEA aimed at identifying disrupted signaling pathways
as well as analyses to identify individual, differentially
expressed genes between spt and wild-type tissue. Our
results demonstrate that retinoic acid signaling is under
the control of tbx16 at both developmental stages/tis-
sues. In addition, we reveal that Wnt signaling is under
the control of tbx16 in the zebrafish intermediate meso-
derm at the 4/5-somite stage. This suggests a novel role
for Wnt signaling in zebrafish primitive red blood cell
formation, adding to an emerging picture of the many
roles of Wnt signaling during hematopoiesis. We also
identify novel tbx16 targets outside of both pathways.
Our results contribute to a growing body of research
a i m e da ti d e n t i f y i n gT - b o xt a r g e tg e n e sa sw e l la s
elucidating the genetic regulation of embryonic red
blood cell formation in vertebrates.
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